The first Apellis Pharmaceuticals trade was made in Q4 2018.
Since then Steven Cohen bought shares six more times and sold shares on six occasions. The investor completely sold their stake between Q2 2023 and Q3 2023.
Avg closing price
Price range
Sold -1.24 Million shares
Q3 2023
Avg closing price
$43.93
Price range
$23.65
-
$89.22
Sold 34.1% shares (-640 Thousand shares)
Q2 2023
Avg closing price
$86.28
Price range
$76.68
-
$93.31
New holding (+1.88 Million shares)
Q1 2023
Avg closing price
$57.70
Price range
$46.59
-
$66.96
Sold -250 Thousand shares
Q2 2021
Avg closing price
$51.60
Price range
$40.90
-
$64.90
Increased shares by 968.4% (+227 Thousand shares)
Q1 2021
Avg closing price
$47.32
Price range
$40.80
-
$57.39
Sold 94.8% shares (-424 Thousand shares)
Q4 2020
Avg closing price
$42.30
Price range
$30.79
-
$57.20
Increased shares by 114.8% (+239 Thousand shares)
Q3 2020
Avg closing price
$29.88
Price range
$25.89
-
$33.66
Sold 35.0% shares (-112 Thousand shares)
Q2 2020
Avg closing price
$32.11
Price range
$24.80
-
$38.49
New holding (+320 Thousand shares)
Q1 2020
Avg closing price
$35.50
Price range
$17.91
-
$44.33
Sold -401 Thousand shares
Q3 2019
Avg closing price
$27.52
Price range
$24.09
-
$32.18
Increased shares by 20.2% (+67.5 Thousand shares)
Q2 2019
Avg closing price
$20.35
Price range
$18.00
-
$25.34
Increased shares by 200.5% (+223 Thousand shares)
Q1 2019